Active Ingredient: Heparin
For this indication, competent medicine agencies globally authorize below treatments:
Intravenous
50 - 100 [iU] per kg of body weight
From 50 To 100 [iU] per kg of body weight once every day
Loading dose: 50 units/kg intravenously.
Maintenance: 15-25 units/kg/hour by intravenous infusion, or 100 units/kg 4-hourly by intravenous injection.
Daily laboratory monitoring (ideally at the same time each day, starting 4-6 hours after initiation of treatment) is essential during full-dose heparin treatment, with adjustment of dosage to maintain an APTT value 1.5-2.5 x midpoint of normal range or control value.
By continuous intravenous infusion in 5% glucose or 0.9% sodium chloride or by intermittent intravenous injection.
The intravenous injection volume of heparin injection should not exceed 15ml.
As the effects of heparin are short-lived, administration by intravenous infusion is preferable to intermittent intravenous injections.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.
